Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:108b
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 108B
Character Range: 55998–59124

108B  Vaccine                                                                                                                                                                                                                                                                                Menveo             Injection (0.5mL)                                                                 Each 0.5 mL dose contains:                                                                                                                                                                                                                                                                                                                                     1 dose
      Meningococcal (Groups A,C,W‑135 and Y) Oligosaccharide CRM197 Conjugate Vaccine (Men ACWY‑CRM)
      Circumstances                                                                                                                                                                                                                                                                                                                                                                                   (a) 10 µg Meningococcal polysaccharide serogroup A conjugated to 16.7–33.3 µg Corynebacterium diphtheriae CRM197 protein
      Vaccine may be provided to:                                                                                                                                                                                                                                                                                                                                                                     (b) 5 µg Meningococcal polysaccharide serogroup C conjugated to 7.1–12.5 µg C. diphtheriae CRM197 protein
       (a) a person aged at least 14 years old but less than 17 years old as part of a school based program; or                                                                                                                                                                                                                                                                                       (c) 5 µg Meningococcal polysaccharide serogroup W‑135 conjugated to 3.3–8.3 µg C. diphtheriae CRM197 protein
       (b) a person aged at least 14 years old but less than 19 years old who did not receive the vaccination as part of a school based program; or                                                                                                                                                                                                                                                   (d) 5 µg Meningococcal polysaccharide serogroup Y conjugated to 5.6–10 µg C. diphtheriae CRM197 protein
       (c) a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.